Akorn, Inc. (AKN) Announces Second Quarter 2009 Earnings Release and Conference Call Information
7/30/2009 11:32:36 AM
More...
|
Akorn, Inc. (AKN) Announces Second Quarter 2009 Earnings Release and Conference Call Information
7/29/2009 9:36:31 AM
More...
|
Akorn, Inc. (AKN) Acquires Capastat(R) Sulfate from Eli Lilly and Company (LLY)
6/17/2009 9:33:59 AM
More...
|
Akorn, Inc. (AKN) Announces Management Changes
6/9/2009 9:24:19 AM
More...
|
Akorn, Inc. (AKN) Reports First Quarter 2009 Financial Results
5/12/2009 11:02:45 AM
More...
|
Akorn, Inc. (AKN) Appoints Jeffrey A. Whitnell as Interim Chief Executive Officer
3/30/2009 8:45:38 AM
More...
|
Akorn, Inc. (AKN) Appoints Raj Rai as Strategic Consultant
3/2/2009 8:34:09 AM
More...
|
Akorn, Inc. (AKN) Amplifies Form 8-K Disclosure
2/26/2009 9:22:00 AM
More...
|
Akorn, Inc. (AKN) CEO Leaves Company
1/30/2009 6:39:25 AM
More...
|
Akorn, Inc. (AKN) Responds to FDA Draft Guidance for Industry on Bioequivalence Recommendation for Vancomycin HCl
12/16/2008 8:30:28 AM
More...
|
|